These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 6091965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dopamine agonists as primary treatment in Parkinson's disease.
    Rinne UK.
    Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
    [No Abstract] [Full Text] [Related]

  • 3. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract] [Full Text] [Related]

  • 4. [Use of dopamine agonists in the treatment of Parkinson's disease].
    Gekht AB.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):54-8. PubMed ID: 12378886
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine agonists in Parkinson's disease.
    Calne DB, Burton K, Beckman J, Martin WR.
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):221-4. PubMed ID: 6231979
    [Abstract] [Full Text] [Related]

  • 6. [Dopamine agonists in the therapy of parkinson syndrome].
    Kapfhammer HP, Rüther E.
    Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
    [No Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of dopamine agonists in Parkinson's disease.
    Lange KW.
    Drugs Aging; 1998 Nov; 13(5):381-9. PubMed ID: 9829165
    [Abstract] [Full Text] [Related]

  • 8. Sleep attacks and Parkinson's disease treatment.
    Ferreira JJ, Galitzky M, Montastruc JL, Rascol O.
    Lancet; 2000 Apr 15; 355(9212):1333-4. PubMed ID: 10776750
    [Abstract] [Full Text] [Related]

  • 9. Current status of dopamine agonists in Parkinson's disease management.
    Montastruc JL, Rascol O, Senard JM.
    Drugs; 1993 Sep 15; 46(3):384-393. PubMed ID: 7693430
    [Abstract] [Full Text] [Related]

  • 10. [Dopaminergic agonists in Parkinson disease].
    Dubois B, Agid Y.
    Rev Prat; 1986 Jan 21; 36(5):207-14. PubMed ID: 3961400
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
    Agid Y, Barroche G, Bonnet AM, Javoy-Agid F, Kato G, Lhermitte F, Pollak P, Signoret JL.
    Biomedicine; 1979 Jun 21; 30(2):67-71. PubMed ID: 383169
    [Abstract] [Full Text] [Related]

  • 12. Pergolide and lisuride in advanced Parkinson's disease.
    Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Goldstein M.
    Adv Neurol; 1984 Jun 21; 40():503-7. PubMed ID: 6695627
    [Abstract] [Full Text] [Related]

  • 13. Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
    Lang AE.
    Can J Neurol Sci; 1987 Aug 21; 14(3 Suppl):474-82. PubMed ID: 3315148
    [Abstract] [Full Text] [Related]

  • 14. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Goetz CG, Poewe W, Rascol O, Sampaio C.
    Mov Disord; 2005 May 21; 20(5):523-39. PubMed ID: 15818599
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic agonists in the treatment of Parkinson's disease.
    Goetz CG, Diederich NJ.
    Neurol Clin; 1992 May 21; 10(2):527-40. PubMed ID: 1350052
    [Abstract] [Full Text] [Related]

  • 16. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK.
    Arch Neurobiol (Madr); 1991 May 21; 54(6):282-7. PubMed ID: 1687430
    [No Abstract] [Full Text] [Related]

  • 17. Use of apomorphine in Parkinson's disease.
    Stocchi F.
    Neurol Sci; 2008 Dec 21; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [Abstract] [Full Text] [Related]

  • 18. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M, Reichmann H, Riederer P.
    Mov Disord; 2005 May 21; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract] [Full Text] [Related]

  • 19. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
    Goetz CG, Tanner CM, Glantz RH, Klawans HL.
    Neurology; 1985 May 21; 35(5):749-51. PubMed ID: 3990974
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
    Schneider E, Hubener K, Fischer PA.
    Neurology; 1983 Apr 21; 33(4):468-72. PubMed ID: 6682193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.